-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Chinook Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2014 to Q2 2023.
- Chinook Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 71.6M shares, a 15.5% increase year-over-year.
- Chinook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 64.4M shares, a 41.1% increase from 2021.
- Chinook Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 45.6M shares, a 246% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)